speb/financial-data huggingface dataset:
SANG cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -203000.00
SANG income_statement (quarterly, 2025-12-31) — Net Income: -1996000.00
SANG income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -1996000.00
SANG income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -1996000.00
SANG income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1996000.00
SANG income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1996000.00
SANG cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -1996000.00
SANG income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -1996000.00
SANG cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -1671000.00
SANG income_statement (quarterly, 2025-12-31) — Net Interest Income: -476000.00
SANG cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -5614000.00
SANG cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -5614000.00
SANG income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -476000.00
SANG balance_sheet (quarterly, 2025-12-31) — Net PPE: 11869000.00
SANG cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -4922000.00
SANG balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -20211000.00
SANG balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 1539000.00
SANG balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 1128000.00
SANG balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 5254000.00
SANG balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 2735000.00
SANG balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1128000.00
SANG balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2519000.00
SANG income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 9184000.00
SANG income_statement (quarterly, 2025-12-31) — Normalized Income: -1877027.44
SANG cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 10131000.00
SANG cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -181000.00
SANG income_statement (quarterly, 2025-12-31) — Operating Income: -1717000.00
SANG income_statement (quarterly, 2025-12-31) — Operating Revenue: 51450000.00
SANG balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 33199364.00
SANG balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 4276000.00
SANG balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 20600000.00
SANG balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -159000.00
SANG income_statement (quarterly, 2025-12-31) — Other Gand A: 8632000.00
SANG income_statement (quarterly, 2025-12-31) — Other Income Expense: -139000.00
SANG balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 83412000.00
SANG cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 70000.00
SANG balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 724000.00
SANG balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1244000.00
SANG balance_sheet (quarterly, 2025-12-31) — Other Properties: 30960000.00
SANG balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1135000.00
SANG balance_sheet (quarterly, 2025-12-31) — Payables: 18668000.00
SANG balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 18668000.00
SANG income_statement (quarterly, 2025-12-31) — Pretax Income: -2332000.00
SANG cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
SANG balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
SANG cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -422000.00
SANG balance_sheet (quarterly, 2025-12-31) — Raw Materials: 4705000.00
SANG balance_sheet (quarterly, 2025-12-31) — Receivables: 11125000.00
SANG income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 10576000.00
SANG income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 10795000.00
SANG cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -5614000.00
SANG cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -984000.00
SANG income_statement (quarterly, 2025-12-31) — Research And Development: 10412000.00
SANG balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 16000.00
SANG income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 139000.00
SANG balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -151278000.00
SANG income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 12752000.00
SANG income_statement (quarterly, 2025-12-31) — Selling General And Administration: 21384000.00
SANG balance_sheet (quarterly, 2025-12-31) — Share Issued: 33199364.00
SANG income_statement (quarterly, 2025-12-31) — Special Income Charges: -139000.00
SANG cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 830000.00
SANG balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 250041000.00
SANG balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -20211000.00
SANG income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -20027.44
SANG income_statement (quarterly, 2025-12-31) — Tax Provision: -336000.00
SANG income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.14
SANG balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 673000.00
SANG cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -89000.00
SANG balance_sheet (quarterly, 2025-12-31) — Total Assets: 325426000.00
SANG balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 267041000.00
SANG balance_sheet (quarterly, 2025-12-31) — Total Debt: 45207000.00
SANG balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 250041000.00
SANG income_statement (quarterly, 2025-12-31) — Total Expenses: 53167000.00
SANG balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 75385000.00
SANG balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 285516000.00
SANG balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 29583000.00
SANG balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 3230000.00
SANG income_statement (quarterly, 2025-12-31) — Total Unusual Items: -139000.00
SANG income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -139000.00
SANG balance_sheet (quarterly, 2025-12-31) — Working Capital: -5892000.00
SANG income_statement (quarterly, 2026-03-31) — +Operating Expense: 38477000.00
SANG income_statement (quarterly, 2026-03-31) — +Total Revenue: 50995000.00
SANG balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 17291000.00
SANG balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 9654000.00
SANG balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -28045000.00
SANG balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 21349000.00
SANG balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -308000.00
SANG income_statement (quarterly, 2026-03-31) — Amortization: 7974000.00
SANG cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 9495000.00
SANG cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 9495000.00
SANG income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 7974000.00
SANG income_statement (quarterly, 2026-03-31) — Basic Average Shares: 33152692.00
SANG income_statement (quarterly, 2026-03-31) — Basic EPS: -0.07
SANG cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 17123000.00
SANG cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -2398000.00
SANG balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 7265000.00
SANG balance_sheet (quarterly, 2026-03-31) — Capital Stock: 380637000.00
SANG balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 15179000.00
SANG balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 15179000.00
SANG balance_sheet (quarterly, 2026-03-31) — Cash Financial: 15179000.00
SANG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -5505000.00
SANG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -2398000.00
SANG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 5975000.00
SANG cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 1853000.00
SANG cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: -1074000.00
SANG cash_flow (quarterly, 2026-03-31) — Change In Inventory: -91000.00
SANG cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -929000.00
SANG cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 464000.00
SANG cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -1420000.00
SANG cash_flow (quarterly, 2026-03-31) — Change In Payable: 779000.00
SANG cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 779000.00
SANG cash_flow (quarterly, 2026-03-31) — Change In Receivables: -1199000.00
SANG cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: -1074000.00
SANG cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -2396000.00
SANG cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -337000.00
SANG cash_flow (quarterly, 2026-03-31) — Changes In Cash: -1928000.00
SANG balance_sheet (quarterly, 2026-03-31) — Common Stock: 380637000.00
SANG balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 248403000.00
SANG cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
SANG income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 14634000.00
SANG balance_sheet (quarterly, 2026-03-31) — Current Assets: 40687000.00
SANG balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1579000.00
SANG balance_sheet (quarterly, 2026-03-31) — Current Debt: 20600000.00
SANG balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 22179000.00
SANG balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 3482000.00
SANG balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 3482000.00
SANG balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 45302000.00
SANG balance_sheet (quarterly, 2026-03-31) — Current Provisions: 166000.00
SANG cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -586000.00
SANG cash_flow (quarterly, 2026-03-31) — Deferred Tax: -586000.00
SANG cash_flow (quarterly, 2026-03-31) — Depreciation: 1186000.00
SANG cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 10681000.00
SANG income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 7974000.00
SANG cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 10681000.00
SANG income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 7974000.00
SANG income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 33152692.00
SANG income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.07
SANG income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -2335000.00
SANG income_statement (quarterly, 2026-03-31) — EBIT: -2386000.00
SANG income_statement (quarterly, 2026-03-31) — EBITDA: 8295000.00
SANG cash_flow (quarterly, 2026-03-31) — End Cash Position: 15195000.00
SANG balance_sheet (quarterly, 2026-03-31) — Financial Assets: 0.00
SANG cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -5505000.00
SANG balance_sheet (quarterly, 2026-03-31) — Finished Goods: 3543000.00
SANG cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 3577000.00
SANG cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 17000.00
SANG balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 30000.00
SANG income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 7266000.00
SANG balance_sheet (quarterly, 2026-03-31) — Goodwill: 186840000.00
SANG balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 262133000.00
SANG balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 9962000.00
SANG balance_sheet (quarterly, 2026-03-31) — Gross PPE: 39643000.00
SANG income_statement (quarterly, 2026-03-31) — Gross Profit: 36361000.00
SANG balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 100000.00
SANG balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 265000.00
SANG income_statement (quarterly, 2026-03-31) — Interest Expense: 535000.00
SANG income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 535000.00
SANG income_statement (quarterly, 2026-03-31) — Interest Income: 85000.00
SANG income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 85000.00
SANG balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -835000.00
SANG balance_sheet (quarterly, 2026-03-31) — Inventory: 7348000.00
SANG balance_sheet (quarterly, 2026-03-31) — Invested Capital: 280853000.00
SANG cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -2398000.00
SANG balance_sheet (quarterly, 2026-03-31) — Leases: 783000.00
SANG balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 5686000.00
SANG balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 11850000.00
SANG balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 17536000.00
SANG cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -5582000.00
SANG balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 7252000.00
SANG cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
SANG cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
SANG balance_sheet (quarterly, 2026-03-31) — Net Debt: 17271000.00
SANG cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 219000.00
SANG income_statement (quarterly, 2026-03-31) — Net Income: -2335000.00
SANG income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -2335000.00
SANG income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -2335000.00
SANG income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -2335000.00
SANG income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -2335000.00
SANG cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -2335000.00
SANG income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -2335000.00
SANG cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -1498000.00
SANG income_statement (quarterly, 2026-03-31) — Net Interest Income: -450000.00
SANG cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -5582000.00
SANG cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -5582000.00
SANG income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -450000.00
SANG balance_sheet (quarterly, 2026-03-31) — Net PPE: 11598000.00
SANG cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -900000.00
SANG balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -13730000.00
SANG balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 1456000.00
SANG balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 1141000.00
SANG balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 4475000.00
SANG balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 2679000.00
SANG balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1141000.00
SANG balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1796000.00
SANG income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 8650000.00
SANG income_statement (quarterly, 2026-03-31) — Normalized Income: -2051218.76
SANG cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 5975000.00
SANG cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 236000.00
SANG income_statement (quarterly, 2026-03-31) — Operating Income: -2116000.00
SANG income_statement (quarterly, 2026-03-31) — Operating Revenue: 50995000.00
SANG balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 33278790.00
SANG balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 5520000.00
SANG balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 20600000.00
SANG balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 30000.00
SANG income_statement (quarterly, 2026-03-31) — Other Gand A: 7266000.00
SANG income_statement (quarterly, 2026-03-31) — Other Income Expense: -355000.00
SANG balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 75293000.00
SANG cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 51000.00
SANG balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 409000.00
SANG balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1708000.00
SANG balance_sheet (quarterly, 2026-03-31) — Other Properties: 31608000.00
SANG balance_sheet (quarterly, 2026-03-31) — Other Receivables: 1079000.00
SANG balance_sheet (quarterly, 2026-03-31) — Payables: 19475000.00
SANG balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 19475000.00
SANG income_statement (quarterly, 2026-03-31) — Pretax Income: -2921000.00
SANG cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 77000.00
SANG balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
SANG cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -1498000.00
SANG cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -900000.00
SANG balance_sheet (quarterly, 2026-03-31) — Raw Materials: 4640000.00
SANG balance_sheet (quarterly, 2026-03-31) — Receivables: 12524000.00
SANG income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 11927000.00
SANG income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 10681000.00
SANG cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -5582000.00
SANG cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
SANG income_statement (quarterly, 2026-03-31) — Research And Development: 10771000.00
SANG balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 16000.00
SANG income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 355000.00
SANG balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -153613000.00
SANG cash_flow (quarterly, 2026-03-31) — Sale Of Business: 0.00
SANG income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 12466000.00
SANG income_statement (quarterly, 2026-03-31) — Selling General And Administration: 19732000.00
SANG balance_sheet (quarterly, 2026-03-31) — Share Issued: 33278790.00
SANG income_statement (quarterly, 2026-03-31) — Special Income Charges: -355000.00
SANG cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 431000.00
SANG balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 248403000.00
SANG balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -13730000.00
SANG income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -71218.76
SANG income_statement (quarterly, 2026-03-31) — Tax Provision: -586000.00
SANG income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.20
SANG balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 1791000.00
SANG cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -107000.00
SANG balance_sheet (quarterly, 2026-03-31) — Total Assets: 317424000.00
SANG balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 260253000.00
SANG balance_sheet (quarterly, 2026-03-31) — Total Debt: 39715000.00
SANG balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 248403000.00
SANG income_statement (quarterly, 2026-03-31) — Total Expenses: 53111000.00
SANG balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 69021000.00
SANG balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 276737000.00
SANG balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 23719000.00
SANG balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 2184000.00
SANG income_statement (quarterly, 2026-03-31) — Total Unusual Items: -355000.00
SANG income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -355000.00
SANG balance_sheet (quarterly, 2026-03-31) — Working Capital: -4615000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -3928000000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 864600000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -28300000.00
SANGAMIND.NS income_statement (annual, 2022-03-31) — Amortization: 10900000.00
SANGAMIND.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 10900000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 77600000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 2349500000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 11300000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 2200000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 1639000000.00
SANGAMIND.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 200500000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 3792600000.00
SANGAMIND.NS income_statement (annual, 2022-03-31) — Interest Income: 41700000.00
SANGAMIND.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 41700000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 318700000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 6587200000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 264900000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Other Payable: 440700000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 452500000.00
SANGAMIND.NS income_statement (annual, 2022-03-31) — Other Special Charges: -12400000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 403100000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 307200000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
SANGAMIND.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: -7000000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 2859000000.00
SANGAMIND.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 18400000.00
SANGAMIND.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 18400000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 211700000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 3292000000.00
SANGAMIND.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 1431200000.00
SANGAMIND.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 1631700000.00
SANGAMIND.NS cash_flow (annual, 2022-03-31) — Stock Based Compensation: 0.00
SANGAMIND.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 48800000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 38400000.00
SANGAMIND.NS balance_sheet (annual, 2022-03-31) — Work In Process: 781700000.00
SANGAMIND.NS income_statement (annual, 2022-03-31) — Write Off: 138100000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — +Operating Expense: 7034700000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — +Total Revenue: 26563600000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 2272600000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 3528200000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -4507000000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 1317700000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -32200000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Amortization: 10800000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 10800000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 0.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 7500000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 44382860.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Basic EPS: 29.41
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 223000000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 2689100000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -3890700000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 26000000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 450500000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 2000000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 70600000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -89300000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 2000000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 146200000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -394300000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 198700000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Change In Payable: -622700000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 160500000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -467300000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 56700000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Common Stock: 450500000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 8831400000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: -110600000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 2983200000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 17070500000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Current Assets: 10665400000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 16500000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Current Debt: 4842000000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 4858500000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 8921400000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 233100000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Depreciation: 783200000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 794000000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 793900000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 783100000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 47885947.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Diluted EPS: 27.26
SANGAMIND.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 1305400000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 2000000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — EBIT: 2075600000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — EBITDA: 2869600000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — End Cash Position: 279700000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 1434400000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 2423800000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -1732900000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -72200000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 316900000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 33300000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 3560400000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 14710500000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Gross Profit: 9493100000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Interest Expense: 479000000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 479000000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Interest Income: 57800000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 57800000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -536100000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 63000000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Inventory: 5133600000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 17068700000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -3535500000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 7500000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: -110600000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 2399900000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 418800000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 9500000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 3395300000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 3404800000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 2399900000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -810100000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 7694300000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: -110600000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Net Debt: 8235300000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 62300000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Net Income: 1305400000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 1305400000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 1305400000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 1305400000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 1305400000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1596600000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 1305400000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Net Interest Income: -481300000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 109900000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 2170400000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 1589800000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -481300000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Net PPE: 10203500000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -3708400000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 580600000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 8798100000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 347000000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 0.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 695900000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 3064500000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Normalized Income: 1456681380.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 2157800000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Operating Income: 2458400000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Operating Revenue: 26563600000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 45011132.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 10500000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 4000000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 234000000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 33300000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Other Investments: 7500000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 481300000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 1139400000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: -100000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 5600000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 3122400000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Other Payable: 672100000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Other Properties: 925100000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 335300000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 68600000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Other Special Charges: 134100000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Payables: 2946700000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 10700000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 451500000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 591400000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Pretax Income: 1596600000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: 0.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -3890700000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 1766400000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 17070500000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 794000000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 17400000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 17400000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -810100000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 277700000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 4516400000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 109900000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 182300000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 908600000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1225500000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Share Issued: 45046559.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Special Income Charges: -194900000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 113800000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 8831400000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 8798100000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -43618620.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Tax Provision: 291200000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.22
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 718100000.00
SANGAMIND.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -434200000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Total Assets: 21605600000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 12226700000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Total Debt: 8263300000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 8831400000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Total Expenses: 24105200000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 12774200000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 10940200000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 3852800000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 60100000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 0.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -194900000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -194900000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 35427.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Work In Process: 943400000.00
SANGAMIND.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1744000000.00
SANGAMIND.NS income_statement (annual, 2023-03-31) — Write Off: 60800000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — +Operating Expense: 7216700000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — +Total Revenue: 25503000000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 4271800000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 4484100000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -5098000000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 2201700000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -66600000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Amortization: 11300000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 11300000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 7500000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 49732312.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Basic EPS: 8.21
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 279700000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 3552500000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -4082800000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 9400000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 502500000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 1700000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 104400000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -101000000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 1700000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -1554800000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -257100000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 225600000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Change In Payable: 1997200000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -1003800000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -491800000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 3000000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Common Stock: 502500000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 9843300000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 702000000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 3121300000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 17061400000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Current Assets: 13568300000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 6000000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Current Debt: 4463000000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 4469000000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 10700000000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 145700000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Defined Pension Benefit: 0.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Depreciation: 956800000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 968100000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 968100000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 956800000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 49732312.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Diluted EPS: 8.21
SANGAMIND.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 408200000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 1500000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — EBIT: 1183700000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — EBITDA: 2151800000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — End Cash Position: 282700000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 2298100000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 2642600000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -2482200000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -29700000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -3900000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 315800000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 51800000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 4550700000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 17331700000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Gross Profit: 8441600000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Interest Expense: 649800000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 649800000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Interest Income: 50700000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 50700000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -715700000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 39300000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Inventory: 6694200000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 20493500000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -3895700000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 7500000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 702000000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 3385600000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 456400000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 3400000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 6187200000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 6190600000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 3385600000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -543900000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 190800000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 9831500000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 702000000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Net Debt: 10648500000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 16200000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Net Income: 408200000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 408200000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 408200000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 408200000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 408200000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 533900000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 408200000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Net Interest Income: -663600000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -4400000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 2412800000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 2841700000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -663600000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Net PPE: 13169500000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -3930600000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -428900000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 9791500000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 364700000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 190800000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 492200000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 2211800000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Normalized Income: 453938000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 1600600000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Operating Income: 1224900000.00
SANGAMIND.NS income_statement (annual, 2024-03-31) — Operating Revenue: 25503000000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 49826038.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 149400000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 2000000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 9340700000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 51800000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Other Investments: 7500000.00
SANGAMIND.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 663600000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 1153100000.00
SANGAMIND.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: -100000.00